These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 26586608)

  • 1. A small n sequential multiple assignment randomized trial design for use in rare disease research.
    Tamura RN; Krischer JP; Pagnoux C; Micheletti R; Grayson PC; Chen YF; Merkel PA
    Contemp Clin Trials; 2016 Jan; 46():48-51. PubMed ID: 26586608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sample size determination for Bayesian analysis of small n sequential, multiple assignment, randomized trials (snSMARTs) with three agents.
    Wei B; Braun TM; Tamura RN; Kidwell K
    J Biopharm Stat; 2020 Nov; 30(6):1109-1120. PubMed ID: 32892710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Group sequential methods for cluster randomization trials with binary outcomes.
    Zou GY; Donner A; Klar N
    Clin Trials; 2005; 2(6):479-87. PubMed ID: 16422308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic treatment regimens in small n, sequential, multiple assignment, randomized trials: An application in focal segmental glomerulosclerosis.
    Chao YC; Trachtman H; Gipson DS; Spino C; Braun TM; Kidwell KM
    Contemp Clin Trials; 2020 May; 92():105989. PubMed ID: 32200006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and analysis considerations for utilizing a mapping function in a small sample, sequential, multiple assignment, randomized trials with continuous outcomes.
    Hartman H; Tamura RN; Schipper MJ; Kidwell KM
    Stat Med; 2021 Jan; 40(2):312-326. PubMed ID: 33111381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient ways exist to obtain the optimal sample size in clinical trials in rare diseases.
    van der Lee JH; Wesseling J; Tanck MW; Offringa M
    J Clin Epidemiol; 2008 Apr; 61(4):324-30. PubMed ID: 18313556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of simulation to compare the performance of minimization with stratified blocked randomization.
    Toorawa R; Adena M; Donovan M; Jones S; Conlon J
    Pharm Stat; 2009; 8(4):264-78. PubMed ID: 18756580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Bayesian sequential design with adaptive randomization for 2-sided hypothesis test.
    Yu Q; Zhu L; Zhu H
    Pharm Stat; 2017 Nov; 16(6):451-465. PubMed ID: 28980435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Power prior models for estimating response rates in a small n, sequential, multiple assignment, randomized trial.
    Chao YC; Braun TM; Tamura RN; Kidwell KM
    Stat Methods Med Res; 2022 Dec; 31(12):2297-2309. PubMed ID: 36082955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical Considerations and Software for Designing Sequential, Multiple Assignment, Randomized Trials (SMART) with a Survival Final Endpoint.
    Kravets S; Ruppert AS; Jacobson SB; Le-Rademacher JG; Mandrekar SJ
    J Biopharm Stat; 2024 Jul; 34(4):539-552. PubMed ID: 37434437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sample size of randomized double-blind trials 1976-1991.
    Mulward S; Gotzsche PC
    Dan Med Bull; 1996 Feb; 43(1):96-8. PubMed ID: 8906985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A group sequential, response-adaptive design for randomized clinical trials.
    Karrison TG; Huo D; Chappell R
    Control Clin Trials; 2003 Oct; 24(5):506-22. PubMed ID: 14500050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exact group-sequential designs for clinical trials with randomized play-the-winner allocation.
    Stallard N; Rosenberger WF
    Stat Med; 2002 Feb; 21(4):467-80. PubMed ID: 11836730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive design and estimation in randomized clinical trials with correlated observations.
    Yin G; Shen Y
    Biometrics; 2005 Jun; 61(2):362-9. PubMed ID: 16011682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Group sequential and adaptive designs: a novel, promising tool for nursing research.
    Baldi I; Gouchon SM; Di Giulio P; Buja A; Gregori D
    J Adv Nurs; 2011 Aug; 67(8):1824-33. PubMed ID: 21517937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of error rates in single-arm versus randomized phase II cancer clinical trials.
    Tang H; Foster NR; Grothey A; Ansell SM; Goldberg RM; Sargent DJ
    J Clin Oncol; 2010 Apr; 28(11):1936-41. PubMed ID: 20212253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample size re-estimation in cluster randomization trials.
    Lake S; Kammann E; Klar N; Betensky R
    Stat Med; 2002 May; 21(10):1337-50. PubMed ID: 12185888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An adaptive group sequential phase II design to compare treatments for survival endpoints in rare patient entities.
    Wunder C; Kopp-Schneider A; Edler L
    J Biopharm Stat; 2012; 22(2):294-311. PubMed ID: 22251175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing sample sizes in two-stage phase II cancer trials by using continuous tumour shrinkage end-points.
    Wason JM; Mander AP; Eisen TG
    Eur J Cancer; 2011 May; 47(7):983-9. PubMed ID: 21239164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptive survival trials.
    Rosenberger WF; Seshaiyer P
    J Biopharm Stat; 1997 Nov; 7(4):617-24. PubMed ID: 9358333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.